The optimal timing for non-cardiac surgery after percutaneous coronary intervention with drug-eluting stents
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Cheol Ung | - |
dc.contributor.author | Rha, Seung-Woon | - |
dc.contributor.author | Jin, Zhe | - |
dc.contributor.author | Chen, Kang-yin | - |
dc.contributor.author | Minami, Yoshiyasu | - |
dc.contributor.author | Kim, Ji Hoon | - |
dc.contributor.author | Na, Jin Oh | - |
dc.contributor.author | Suh, Soon Yong | - |
dc.contributor.author | Kim, Jin Won | - |
dc.contributor.author | Kim, Eung Ju | - |
dc.contributor.author | Park, Chang Gyu | - |
dc.contributor.author | Seo, Hong Seog | - |
dc.contributor.author | Oh, Dong Joo | - |
dc.date.available | 2020-11-03T06:48:40Z | - |
dc.date.issued | 2010-03-18 | - |
dc.identifier.issn | 0167-5273 | - |
dc.identifier.issn | 1874-1754 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/15065 | - |
dc.description.abstract | This study was to assess the optimal timing for non-cardiac surgery (NCS) after drug-eluting stents (DES) implantation in patients who are scheduled for NCS. In conclusions, patients undergoing early NCS within 3 months after the PCI with DES may associate with adverse outcomes. Therefore we suggest that NCS should be deferred at least 3 months after the DES implantation. (C) 2008 Elsevier Ireland Ltd. All rights reserved. | - |
dc.format.extent | 4 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ELSEVIER IRELAND LTD | - |
dc.title | The optimal timing for non-cardiac surgery after percutaneous coronary intervention with drug-eluting stents | - |
dc.type | Article | - |
dc.publisher.location | 아일랜드 | - |
dc.identifier.doi | 10.1016/j.ijcard.2008.10.050 | - |
dc.identifier.scopusid | 2-s2.0-80052540267 | - |
dc.identifier.wosid | 000276810100021 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF CARDIOLOGY, v.139, no.3, pp 313 - 316 | - |
dc.citation.title | INTERNATIONAL JOURNAL OF CARDIOLOGY | - |
dc.citation.volume | 139 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 313 | - |
dc.citation.endPage | 316 | - |
dc.type.docType | Letter | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | ANTIPLATELET THERAPY | - |
dc.subject.keywordPlus | FOLLOW-UP | - |
dc.subject.keywordPlus | THROMBOSIS | - |
dc.subject.keywordPlus | DISCONTINUATION | - |
dc.subject.keywordPlus | IMPLANTATION | - |
dc.subject.keywordAuthor | Drug-eluting stent | - |
dc.subject.keywordAuthor | Percutaneous coronary intervention | - |
dc.subject.keywordAuthor | Non-cardiac surgery | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.